Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):301-309. doi: 10.1016/j.hbpd.2018.05.005. Epub 2018 May 24.
Hepatobiliary Pancreat Dis Int. 2018.
PMID: 29861325
Review.